Search Legislation

Commission Implementing Regulation (EU) 2019/2007Show full title

Commission Implementing Regulation (EU) 2019/2007 of 18 November 2019 laying down rules for the application of Regulation (EU) 2017/625 of the European Parliament and of the Council as regards the lists of animals, products of animal origin, germinal products, animal by-products and derived products and hay and straw subject to official controls at border control posts and amending Decision 2007/275/EC (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

Point in time view as at 18/11/2019.

Changes to legislation:

There are currently no known outstanding effects for the Commission Implementing Regulation (EU) 2019/2007, General remarks . Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

General remarks U.K.

Finished medicinal products, which are not covered by Regulation (EC) No 1069/2009 and (EU) No 142/2011, are excluded from the list. Intermediate products are included.

In heading 3001 (glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included) only animal derived products of subheadings 3001 20 and 3001 90 are relevant for official controls. Refer to the following specific requirements in Annex XIV to Regulation (EU) No 142/2011:

1.

Row 2 of Table 2 in Section 1 of Chapter II for blood products for technical products excluding from equidae, and

2.

Row 3 of Table 2 in Section 1 of Chapter II for blood and blood products from equidae, and

3.

Row 14 of Table 2 in Section 1 of Chapter II for animal by-products for the manufacture of pet food other than raw pet food and of derived products for uses outside the feed chain.

In heading 3002 (human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products) only subheadings 3002 12 and 3002 90 are relevant for official controls. Human blood of 3002 90 10 and vaccines of subheadings 3002 20 and 3002 30 do not need to be subjected to official controls.

CN codeDescriptionQualification and explanation
(1)(2)(3)
3001 20 90Extracts of glands or other organs or of their secretions, other than of human originAll; covers a product acting as a replacement for maternal colostrum and used in the feeding of calves.
ex 3001 90 91Animal substances prepared for therapeutic or prophylactic uses: heparin and its saltsAll animal products, which are destined for further processing, in accordance with Article 34(1) of Regulation (EC) No 1069/2009, for the manufacture of the derived products referred to in points (a) to (f) of Article 33 of that Regulation.
3001 90 98Other animal substances than heparin and its salts prepared for therapeutic or prophylactic uses, not elsewhere specified or included

All.

In addition to the glands and other organs mentioned in the Harmonized System Explanatory Notes to heading 3001, (A), this subheading covers the hypophysis, the suprarenal capsules and the thyroid gland; except those specified in Article 33 of Regulation (EC) No 1069/2009.

ex 3002 12 00Antisera and other blood fractions

Animal derived products only.

Excludes finished medicinal products for the final consumer.

Excludes antibodies and DNA.

Under heading 3002, specific requirements are set out for animal by-products covered by Table 2 in Section 1 of Chapter II of Annex XIV to Regulation (EU) No 142/2011 and specified in the following Rows:

Row 2: blood products other than from equidae;

Row 3: blood and blood products from equidae.

3002 90 30Animal blood prepared for therapeutic, prophylactic or diagnostic usesAll
ex 3002 90 50Cultures of micro organismsOnly pathogens and cultures of pathogens for animals.
ex 3002 90 90OtherOnly pathogens and cultures of pathogens for animals.
ex 3006 92 00Waste pharmaceuticals

Animal derived products only.

Pharmaceutical waste, pharmaceutical products, which are unfit for their original intended purpose.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources